Synageva Biopharma


Wednesday Pre-Market Insights: GEVA, BRDR, MGI, NDLS, ZU

Synageva Biopharma Corp (NASDAQ:GEVA) increased more than 130% to $221.25 in pre-market trading following news that the pharmaceutical company will be acquired by …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts